MAP2K7 and melanoma: In summary, our data demonstrate that MEK inhibition of BRAFV600E-positive melanoma cells can lead to AKT-dependent enhanced apoptosis resistance towards genotoxic stress, implying a careful choice of pathway inhibitors in combination therapies.